To further elucidate the complex interaction between microglial activation and clinical phenotype and progression in MSA and other neurodegenerative disorders, longitudinal combined clinical and imaging studies are needed that also investigate other aspects of microglial activation apart from TSPO expression.25 The gene discussed is TSPO; the disease is multiple system atrophy.